Showing 1661-1670 of 3492 results for "".
Case Report: Treatment of Refractory Pemphigus Foliaceus with Rituximab; Financial Matters; AAD; ASDS Resources
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-treatment-of-refractory-pemphigus-foliaceus-with-rituximab-financial-matters-aad-asds-resources/21033/Primary Care Providers as Allies in Dermatology
https://practicaldermatology.com/topics/practice-management/primary-care-providers-as-allies-in-dermatology/21117/In light of a dermatology workforce shortage, PCPs see a majority of skin-related cases. Dermatologists can work with them to improve patient care.Body Dysmorphic Disorder Screening Tools for the Dermatologist: A Systematic Review
https://practicaldermatology.com/topics/general-topics/body-dysmorphic-disorder-screening-tools-for-the-dermatologist-a-systematic-review-s/21231/Experts React to Latest Benzene Analysis
https://practicaldermatology.com/videos/dermwire-tv/experts-react-to-latest-benzene-analysis/29810/In this week's DermwireTV, Practical Dermatology Editorial Board members provide their thoughts on the recent analysis examining benzene concentrations in BPO products; Johnson & Johnson seeks new indications for IL-23 inhibitor Tremfya; and the founder and CEO of Terns discusses plans to improvOrtho Dermatologics NDA, J&J Innovation, Consumer Credit Insights
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-ortho-dermatologics-nda-j-j-innovation-consumer-credit-insights/18395/Two-thirds of prospective patients say they would be more likely to book a procedure if they were aware of financing options. More than three-quarters of prospective patients are unaware of financing options, according to a recent survey by Zalea. In conjunction with Johnson & Johnson Consumer,DermwireTV: Rinvoq Approved for Pediatric Psoriatic Arthritis; J&J Acquires Novel AD Candidate
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-rinvoq-approved-for-pediatric-psoriatic-arthritis/26269/In this week's DermwireTV, the FDA approves Rinvoq for pediatric psoriatic arthritis; Johnson & Johnson acquires an AD candidate for $1.25 billion; and the president of Acclaro Medical discusses the latest FDA clearance of its Ultraclear Laser.DermwireTV: J&J Boosts Dermatology Pipeline; New Humira Biosimilar Launched
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-jj-boosts-dermatology-pipeline-new-humira-biosimilar-launched/24561/In this episode of DermwireTV, Johnson & Johnson makes a major acquisition to expand its dermatology treatment pipeline; the first high-concentration, citrate-free biosimilar to Humira is launched in the US; and in the C-Suite Chats feature, the CEO of Benev discusses the medical aesthetic markeRecent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-4/23071/Vitiligo: An Update on Treatment Options
https://practicaldermatology.com/topics/skin-of-color/vitiligo-an-update-on-treatment-options/23995/From phototherapy to immunosuppresants to topical therapies, there are a number of treatment options for vitiligo.Finding the Perfect Sunscreen for Patients with Skin of Color
https://practicaldermatology.com/columns/skin-cancer-essentials/finding-the-perfect-sunscreen-for-patients-with-skin-of-color/56391/There are a few existing resources that have reviewed and rated sunscreen products and their components;5 few are in scientific journals, and many are short magazine review articles with only a few selections discussed. A team of experts provides comprehensive resource on sunscreens compatible with